ZMPSTE24, an integral membrane zinc metalloprotease with a connection to progeroid disorders

Biological Chemistry

Volumn 390, Issue 8, 2009, Pages 761-773

  Barrowman, Jemima ^a   Michaelis, Susan ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

A factor; Hutchinson Gilford Progeria Syndrome (HGPS); Mandibuloacral dysplasia (MAD); Prelamin A; Restrictive dermopathy (RD); Ste24

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMIN A; MEMBRANE PROTEIN; METALLOPROTEINASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEINASE INHIBITOR; STE24P PROTEIN; UNCLASSIFIED DRUG; ZMPSTE24 PROTEIN;

AGING; CLINICAL TRIAL; DISEASE SEVERITY; ENDOPLASMIC RETICULUM; HUMAN; MANDIBULAR DYSPLASIA TYPE B; NONHUMAN; PREMATURE AGING; PRIORITY JOURNAL; PROGERIA; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RESTRICTIVE DERMOPATHY; REVIEW; TRANSGENIC MOUSE;

AGING, PREMATURE; AMINO ACID SEQUENCE; ANIMALS; ENZYME INHIBITORS; FARNESYLTRANSTRANSFERASE; HIV PROTEASE INHIBITORS; HUMANS; LAMIN TYPE A; LIPOPROTEINS; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PHEROMONES; PROGERIA; PROTEIN PRECURSORS; SACCHAROMYCES CEREVISIAE PROTEINS;

MAMMALIA;

EID: 70349471060     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.080     Document Type: Review

References (93)

1. Agarwal, A.K. and Garg, A. (2006). Genetic disorders of adipose tissue development, differentiation, and death. Annu. Rev. Genomics Hum. Genet. 7, 175-199
2. Agarwal, A.K., Fryns, J.P., Auchus, R.J., and Garg, A. (2003). Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum. Mol. Genet. 12, 1995-2001
3. Barrowman, J., Hamblet, C., George, C.M., and Michaelis, S. (2008). Analysis of prelamin A biogenesis reveals the nucleus to be a CaaX processing compartment. Mol. Biol. Cell 19, 5398-5408
4. Basso, A.D., Kirschmeier, P., and Bishop, W.R. (2006). Lipid posttranslational modifications. Farnesyl transferase inhibitors. J. Lipid Res. 47, 15-31
5. Bergo, M.O., Gavino, B., Ross, J., Schmidt, W.K., Hong, C., Kendall, L.V., Mohr, A., Meta, M., Genant, H., Jiang, Y., et al. (2002). Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc. Natl. Acad. Sci. USA 99, 13049-13054
6. Boyartchuk, V.L. and Rine, J. (1998). Roles of prenyl protein proteases in maturation of Saccharomyces cerevisiae afactor. Genetics 150, 95-101
7. Boyartchuk, V.L., Ashby, M.N., and Rine, J. (1997). Modulation of Ras and a-factor function by carboxyl-terminal proteolysis. Science 275, 1796-1800
8. Brodsky, G.L., Bowersox, J.A., Fitzgerald-Miller, L., Miller, L.A., and Maclean, K.N. (2007). The prelamin A pre-peptide induces cardiac and skeletal myoblast differentiation. Biochem. Biophys. Res. Commun. 356, 872-879
9. Broers, J.L., Ramaekers, F.C., Bonne, G., Yaou, R.B., and Hutchison, C.J. (2006). Nuclear lamins: laminopathies and their role in premature ageing. Physiol. Rev. 86, 967-1008
10. Cadinanos, J., Schmidt, W.K., Fueyo, A., Varela, I., Lopez-Otin, C., and Freije, J.M. (2003). Identification, functional expression and enzymic analysis of two distinct CaaX proteases from Caenorhabditis elegans. Biochem. J. 370, 1047-1054
11. Capell, B.C. and Collins, F.S. (2006). Human laminopathies: nuclei gone genetically awry. Nat. Rev. Genet. 7, 940-952
12. Capell, B.C., Erdos, M.R., Madigan, J.P., Fiordalisi, J.J., Varga, R., Conneely, K.N., Gordon, L.B., Der, C.J., Cox, A.D., and Collins, F.S. (2005). Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson- Gilford progeria syndrome. Proc. Natl. Acad. Sci. USA 102, 12879-12884
13. Capell, B.C., Collins, F.S., and Nabel, E.G. (2007). Mechanisms of cardiovascular disease in accelerated aging syndromes. Circ. Res. 101, 13-26
14. Capell, B.C., Olive, M., Erdos, M.R., Cao, K., Faddah, D.A., Tavarez, U.L., Conneely, K.N., Qu, X., San, H., Ganesh, S.K., et al. (2008). A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proc. Natl. Acad. Sci. USA 105, 15902-15907
15. Caron, M., Auclair, M., Sterlingot, H., Kornprobst, M., and Capeau, J. (2003). Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation. AIDS 17, 2437-2444
16. Caron, M., Auclair, M., Donadille, B., Bereziat, V., Guerci, B., Laville, M., Narbonne, H., Bodemer, C., Lascols, O., Capeau, J., et al. (2007). Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Differ. 14, 1759-1767
17. Chen, P., Sapperstein, S.K., Choi, J.D., and Michaelis, S. (1997). Biogenesis of the Saccharomyces cerevisiae mating pheromone a-factor. J. Cell Biol. 136, 251-269
18. Clarke, S.G. (2007). HIV protease inhibitors and nuclear lamin processing: getting the right bells and whistles. Proc. Natl. Acad. Sci. USA 104, 13857-13858
19. Coffinier, C., Hudon, S.E., Farber, E.A., Chang, S.Y., Hrycyna, C.A., Young, S.G., and Fong, L.G. (2007). HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells. Proc. Natl. Acad. Sci. USA 104, 13432-13437
20. Coffinier, C., Hudon, S.E., Lee, R., Farber, E.A., Nobumori, C., Miner, J.H., Andres, D.A., Spielmann, H.P., Hrycyna, C.A., Fong, L.G., et al. (2008). A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cells. J. Biol. Chem. 283, 9797-9804
21. Dai, Q., Choy, E., Chiu, V., Romano, J., Slivka, S.R., Steitz, S.A., Michaelis, S., and Philips, M.R. (1998). Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum. J. Biol. Chem. 273, 15030-15034
22. Dechat, T., Shimi, T., Adam, S.A., Rusinol, A.E., Andres, D.A., Spielmann, H.P., Sinensky, M.S., and Goldman, R.D. (2007). Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging. Proc. Natl. Acad. Sci. USA 104, 4955-4960
23. Denecke, J., Brune, T., Feldhaus, T., Robenek, H., Kranz, C., Auchus, R.J., Agarwal, A.K., and Marquardt, T. (2006). A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson- Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS. Hum. Mutat. 27, 524-531
24. Eriksson, M., Brown, W.T., Gordon, L.B., Glynn, M.W., Singer, J., Scott, L., Erdos, M.R., Robbins, C.M., Moses, T.Y., Berglund, P., et al. (2003). Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423, 293-298
25. Espada, J., Varela, I., Flores, I., Ugalde, A.P., Cadinanos, J., Pendas, A.M., Stewart, C.L., Tryggvason, K., Blasco, M.A., Freije, J.M., et al. (2008). Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. J. Cell Biol. 181, 27-35
26. Fong, L.G., Ng, J.K., Meta, M., Cote, N., Yang, S.H., Stewart, C.L., Sullivan, T., Burghardt, A., Majumdar, S., Reue, K., et al. (2004). Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice. Proc. Natl. Acad. Sci. USA 101, 18111-18116
27. Fong, L.G., Frost, D., Meta, M., Qiao, X., Yang, S.H., Coffinier, C., and Young, S.G. (2006). A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria. Science 311, 1621-1623
28. Freije, J.M., Blay, P., Pendas, A.M., Cadinanos, J., Crespo, P., and Lopez-Otin, C. (1999). Identification and chromosomal location of two human genes encoding enzymes potentially involved in proteolytic maturation of farnesylated proteins. Genomics 58, 270-280
29. Fujimura-Kamada, K., Nouvet, F.J., and Michaelis, S. (1997). A novel membrane-associated metalloprotease, Ste24p, is required for the first step of NH2-terminal processing of the yeast a-factor precursor. J. Cell Biol. 136, 271-285
30. Gelb, M.H., Brunsveld, L., Hrycyna, C.A., Michaelis, S., Tamanoi, F., Van Voorhis, W.C., and Waldmann, H. (2006). Therapeutic intervention based on protein prenylation and associated modifications. Nat. Chem. Biol. 2, 518-528
31. Glynn, M.W. and Glover, T.W. (2005). Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum. Mol. Genet. 14, 2959-2969
32. Gruenbaum, Y., Margalit, A., Goldman, R.D., Shumaker, D.K., and Wilson, K.L. (2005). The nuclear lamina comes of age. Nat. Rev. Mol. Cell. Biol. 6, 21-31
33. Hegele, R.A., Joy, T.R., Al-Attar, S.A., and Rutt, B.K. (2007). Thematic review series: Adipocyte biology. Lipodystrophies: windows on adipose biology and metabolism. J. Lipid Res. 48, 1433-1444
34. Hudon, S.E., Coffinier, C., Michaelis, S., Fong, L.G., Young, S.G., and Hrycyna, C.A. (2008). HIV-protease inhibitors block the enzymatic activity of purified Ste24p. Biochem. Biophys. Res. Commun. 374, 365-368
35. Huyer, G., Kistler, A., Nouvet, F.J., George, C.M., Boyle, M.L., and Michaelis, S. (2006). Saccharomyces cerevisiae a-factor mutants reveal residues critical for processing, activity, and export. Eukaryot. Cell 5, 1560-1570
36. Jackson, M.R., Nilsson, T., and Peterson, P.A. (1990). Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 9, 3153-3162
37. Kieran, M.W., Gordon, L., and Kleinman, M. (2007). New approaches to progeria. Pediatrics 120, 834-841
38. Kumagai, H., Kawamura, Y., Yanagisawa, K., and Komano, H. (1999). Identification of a human cDNA encoding a novel protein structurally related to the yeast membrane-associated metalloprotease, Ste24p. Biochim. Biophys. Acta 1426, 468-474
39. Leung, G.K., Schmidt, W.K., Bergo, M.O., Gavino, B., Wong, D.H., Tam, A., Ashby, M.N., Michaelis, S., and Young, S.G. (2001). Biochemical studies of Zmpste24-deficient mice. J. Biol. Chem. 276, 29051-29058
40. Liu, B., Wang, J., Chan, K.M., Tjia, W.M., Deng, W., Guan, X., Huang, J.D., Li, K.M., Chau, P.Y., Chen, D.J., et al. (2005). Genomic instability in laminopathy-based premature aging. Nat. Med. 11, 780-785
41. Liu, Y., Rusinol, A., Sinensky, M., Wang, Y., and Zou, Y. (2006). DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A. J. Cell Sci. 119, 4644-4649
42. Lutz, R.J., Trujillo, M.A., Denham, K.S., Wenger, L., and Sinensky, M. (1992). Nucleoplasmic localization of prelamin A: implications for prenylation-dependent lamin A assembly into the nuclear lamina. Proc. Natl. Acad. Sci. USA 89, 3000-3004
43. Mallampalli, M.P., Huyer, G., Bendale, P., Gelb, M.H., and Michaelis, S. (2005). Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutch inson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. USA 102, 14416-14421
44. Manandhar, S.P., Hildebrandt, E.R., and Schmidt, W.K. (2007). Small-molecule inhibitors of the Rce1p CaaX protease. J. Biomol. Screen. 12, 983-993
45. Marino, G., Ugalde, A.P., Salvador-Montoliu, N., Varela, I., Quiros, P.M., Cadinanos, J., van der Pluijm, I., Freije, J.M., and Lopez-Otin, C. (2008). Premature aging in mice activates a systemic metabolic response involving autophagy induction. Hum. Mol. Genet. 17, 2196-2211
46. Mattout, A., Dechat, T., Adam, S.A., Goldman, R.D., and Gruenbaum, Y. (2006). Nuclear lamins, diseases and aging. Curr. Opin. Cell Biol. 18, 335-341
47. McClintock, D., Ratner, D., Lokuge, M., Owens, D.M., Gordon, L.B., Collins, F.S., and Djabali, K. (2007). The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS ONE 2, e1269
48. Meta, M., Yang, S.H., Bergo, M.O., Fong, L.G., and Young, S.G. (2006). Protein farnesyltransferase inhibitors and progeria. Trends Mol. Med. 12, 480-487
49. Miyoshi, Y., Akagi, M., Agarwal, A.K., Namba, N., Kato-Nishimura, K., Mohri, I., Yamagata, M., Nakajima, S., Mushiake, S., Shima, M., et al. (2008). Severe mandibuloacral dysplasia caused by novel compound heterozygous ZMPSTE24 mutations in two Japanese siblings. Clin. Genet. 73, 535-544
50. Morais, P., Magina, S., do Ribeiro, M., Rodrigues, M., Lopes, J.M., Thanh, H.L., Wehnert, M., and Guimarã es, H. (2009). Restrictive dermopathy-a lethal congenital laminopathy. Case report and review of the literature. Eur. J. Pediatr. 168, 1007-1012
51. Moulson, C.L., Go, G., Gardner, J.M., van der Wal, A.C., Smitt, J.H., van Hagen, J.M., and Miner, J.H. (2005). Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy. J. Invest. Dermatol. 125, 913-919
52. Moulson, C.L., Fong, L.G., Gardner, J.M., Farber, E.A., Go, G., Passariello, A., Grange, D.K., Young, S.G., and Miner, J.H. (2007). Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes. Hum. Mutat. 28, 882-889
53. Navarro, C.L., De Sandre-Giovannoli, A., Bernard, R., Boccaccio, I., Boyer, A., Genevieve, D., Hadj-Rabia, S., Gaudy-Marqueste, C., Smitt, H.S., Vabres, P., et al. (2004). Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum. Mol. Genet. 13, 2493-2503
54. Navarro, C.L., Cadinanos, J., De Sandre-Giovannoli, A., Bernard, R., Courrier, S., Boccaccio, I., Boyer, A., Kleijer,W.J.,Wagner, A., Giuliano, F., et al. (2005). Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors. Hum. Mol. Genet. 14, 1503-1513
55. Osorio, F.G., Obaya, A.J., Lopez-Otin, C., and Freije, J.M. (2009). Accelerated ageing: from mechanism to therapy through animal models. Transgenic Res. 18, 7-15
56. Pendas, A.M., Zhou, Z., Cadinanos, J., Freije, J.M., Wang, J., Hultenby, K., Astudillo, A., Wernerson, A., Rodriguez, F., Tryggvason, K., et al. (2002). Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase- deficient mice. Nat. Genet. 31, 94-99
57. Porter, S.B., Hildebrandt, E.R., Breevoort, S.R., Mokry, D.Z., Dore, T.M., and Schmidt, W.K. (2007). Inhibition of the CaaX proteases Rce1p and Ste24p by peptidyl (acyloxy)methyl ketones. Biochim. Biophys. Acta 1773, 853-862
58. Ramirez, C.L., Cadinanos, J., Varela, I., Freije, J.M., and Lopez- Otin, C. (2007). Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questions. Cell. Mol. Life Sci. 64, 155-170
59. Rankin, J. and Ellard, S. (2006). The laminopathies: a clinical review. Clin. Genet. 70, 261-274
60. Ricardo, S. and Lehmann, R. (2009). An ABC transporter controls export of a Drosophila germ cell attractant. Science 323, 943-946
61. Rodriguez, S., Coppede, F., Sagelius, H., and Eriksson, M. (2009). Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging. Eur. J. Hum. Genet., epublication ahead of print; DOI: 10.1038/ejhg.2008.270.
62. Romano, J.D. and Michaelis, S. (2001). Topological and mutational analysis of Saccharomyces cerevisiae Ste14p, founding member of the isoprenylcysteine carboxyl methyltransferase family. Mol. Biol. Cell 12, 1957-1971
63. Rusinol, A.E. and Sinensky, M.S. (2006). Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors. J. Cell Sci. 119, 3265-3272
64. Sander, C.S., Salman, N., van Geel, M., Broers, J.L., Al-Rahmani, A., Chedid, F., Hausser, I., Oji, V., Al Nuaimi, K., Berger, T.G., and Verstraeten, V.L., (2008). A newly identified splice site mutation in ZMPSTE24 causes restrictive dermopathy in the Middle East. Br. J. Dermatol. 159, 961-967
65. Sasseville, A.M. and Raymond, Y. (1995). Lamin A precursor is localized to intranuclear foci. J. Cell Sci. 108, 273-285
66. Scaffidi, P. and Misteli, T. (2006). Lamin A-dependent nuclear defects in human aging. Science 312, 1059-1063
67. Scaffidi, P. and Misteli, T. (2008). Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat. Cell Biol. 10, 452-459
68. Scaffidi, P., Gordon, L., and Misteli, T. (2005). The cell nucleus and aging: tantalizing clues and hopeful promises. PLoS Biol. 3, e395
69. Schmidt, W.K. and Michaelis, S. (2004). The Ste24p protease. In: Handbook of Proteolytic Enzymes, 2nd edn., A.J. Barrett, N. Rawlings and J.F. Woessner, eds. (London, UK: Academic Press), pp. 460-465
70. Schmidt, W.K., Tam, A., Fujimura-Kamada, K., and Michaelis, S. (1998). Endoplasmic reticulum membrane localization of Rce1p and Ste24p, yeast proteases involved in carboxylterminal CAAX protein processing and amino-terminal afactor cleavage. Proc. Natl. Acad. Sci. USA 95, 11175-11180
71. Schmidt, W.K., Tam, A., and Michaelis, S. (2000). Reconstitution of the Ste24p-dependent N-terminal proteolytic step in yeast a-factor biogenesis. J. Biol. Chem. 275, 6227-6233
72. Schuldiner, M., Collins, S.R., Thompson, N.J., Denic, V., Bhamidipati, A., Punna, T., Ihmels, J., Andrews, B., Boone, C., Greenblatt, J.F., et al. (2005). Exploration of the function and organization of the yeast early secretory pathway through an epistatic miniarray profile. Cell 123, 507-519
73. Shackleton, S., Smallwood, D.T., Clayton, P., Wilson, L.C., Agarwal, A.K., Garg, A., and Trembath, R.C. (2005). Compound heterozygous ZMPSTE24 mutations reduce prelamin A processing and result in a severe progeroid phenotype. J. Med. Genet. 42, e36
74. Shumaker, D.K., Dechat, T., Kohlmaier, A., Adam, S.A., Bozovsky, M.R., Erdos, M.R., Eriksson, M., Goldman, A.E., Khuon, S., Collins, F.S., et al. (2006). Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. Proc. Natl. Acad. Sci. USA 103, 8703-8708
75. Sinensky, M., Fantle, K., Trujillo, M., McLain, T., Kupfer, A., and Dalton, M. (1994). The processing pathway of prelamin A. J. Cell Sci. 107, 61-67
76. Sullivan, T., Escalante-Alcalde, D., Bhatt, H., Anver, M., Bhat, N., Nagashima, K., Stewart, C.L., and Burke, B. (1999). Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 147, 913-920
77. Tam, A., Nouvet, F.J., Fujimura-Kamada, K., Slunt, H., Sisodia, S.S., and Michaelis, S. (1998). Dual roles for Ste24p in yeast a-factor maturation: NH2-terminal proteolysis and COOHterminal CAAX processing. J. Cell Biol. 142, 635-649
78. Tam, A., Schmidt, W.K., and Michaelis, S. (2001). The multispanning membrane protein Ste24p catalyzes CAAX proteolysis and NH2-terminal processing of the yeast a-factor precursor. J. Biol. Chem. 276, 46798-46806
79. Tipper, D.J. and Harley, C.A. (2002). Yeast genes controlling responses to topogenic signals in a model transmembrane protein. Mol. Biol. Cell 13, 1158-1174
80. Toth, J.I., Yang, S.H., Qiao, X., Beigneux, A.P., Gelb, M.H., Moulson, C.L., Miner, J.H., Young, S.G., and Fong, L.G. (2005). Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Proc. Natl. Acad. Sci. USA 102, 12873-12878
81. Travers, K.J., Patil, C.K., Wodicka, L., Lockhart, D.J., Weissman, J.S., and Walter, P. (2000). Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101, 249-258
82. Trueblood, C.E., Boyartchuk, V.L., Picologlou, E.A., Rozema, D., Poulter, C.D., and Rine, J. (2000). The CaaX proteases, Afc1p and Rce1p, have overlapping but distinct substrate specificities. Mol. Cell. Biol. 20, 4381-4392
83. Varela, I., Cadinanos, J., Pendas, A.M., Gutierrez-Fernandez, A., Folgueras, A.R., Sanchez, L.M., Zhou, Z., Rodriguez, F.J., Stewart, C.L., Vega, J.A., et al. (2005). Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 437, 564-568
84. Varela, I., Pereira, S., Ugalde, A.P., Navarro, C.L., Suarez, M.F., Cau, P., Cadinanos, J., Osorio, F.G., Foray, N., Cobo, J., et al. (2008). Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat. Med. 14, 767-772
85. Winter-Vann, A.M. and Casey, P.J. (2005). Post-prenylation-processing enzymes as new targets in oncogenesis. Nat. Rev. Cancer 5, 405-412
86. Worman, H.J. and Bonne, G. (2007). 'Laminopathies': a wide spectrum of human diseases. Exp. Cell Res. 313, 2121-2133
87. Wright, L.P. and Philips, M.R. (2006). Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J. Lipid Res. 47, 883-891
88. Yang, S.H., Bergo, M.O., Toth, J.I., Qiao, X., Hu, Y., Sandoval, S., Meta, M., Bendale, P., Gelb, M.H., Young, S.G., et al. (2005). Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson- Gilford progeria syndrome mutation. Proc. Natl. Acad. Sci. USA 102, 10291-10296
89. Yang, S.H., Meta, M., Qiao, X., Frost, D., Bauch, J., Coffinier, C., Majumdar, S., Bergo, M.O., Young, S.G., and Fong, L.G. (2006). A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. J. Clin. Invest. 116, 2115-2121
90. Yang, S.H., Qiao, X., Fong, L.G., and Young, S.G. (2008). Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson-Gilford progeria syndrome mutation. Biochim. Biophys. Acta 1781, 36-39
91. Young, S.G., Fong, L.G., and Michaelis, S. (2005). Prelamin A, Zmpste24, misshapen cell nuclei, and progeria-new evidence suggesting that protein farnesylation could be important for disease pathogenesis. J. Lipid Res. 46, 2531-2558
92. Young, S.G., Meta, M., Yang, S.H., and Fong, L.G. (2006). Prelamin A farnesylation and progeroid syndromes. J. Biol. Chem. 281, 39741-39745
93. Zhang, F.L. and Casey, P.J. (1996). Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65, 241-269